InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-4.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Simon, Christopher, Chairman & CEO. Director active across 2 companies, notably HAEMONETICS CORP. Cumulatively, 24 disclosures have been logged. Split: 0 buy · 9 sells. Total volume traded: €705k. History available since 17 May 2021. The latest transaction was filed on 15 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations24 total
21,405 sharesCommon StockSEC:0001127602-25-015052:0
2,391 shares@ US$69.381.1% of flowCommon StockSEC:0001127602-25-014933:0
39,704 shares@ US$75.5620.3% of flowCommon StockSEC:0001127602-24-023305:0
104,516 shares@ US$41.6429.9% of flowCommon StockSEC:0001127602-24-018160:0
106,062 shares0Common StockSEC:0001127602-24-016803:0
4,037 shares@ US$95.732.7% of flowCommon StockSEC:0001127602-24-016160:0
1,480 shares@ US$96.491.0% of flowCommon StockSEC:0001127602-24-015854:0
38,900 shares0Common StockSEC:0001127602-24-009995:0
196,746 shares@ US$28.61538.8% of flowCommon StockSEC:0001127602-23-019619:0
3,839 shares@ US$83.342.2% of flowCommon StockSEC:0001127602-23-016309:0
18,225 sharesCommon StockSEC:0001127602-23-015925:0
854 shares@ US$88.160.5% of flowCommon StockSEC:0001127602-23-015735:0
8,600 shares0Common StockSEC:0001127602-22-025631:0
1,148 shares@ US$62.600.0026% mcap14.4% of flowCommon StockSEC:0001127602-22-017539:0
2,496 shares@ US$59.100.0053% mcap29.1% of flowCommon StockSEC:0001127602-22-015375:0
832 shares@ US$56.100.0017% mcap9.3% of flowCommon StockSEC:0001127602-22-014951:0
1,200 shares@ US$59.8726.2% of flowCommon StockSEC:0001127602-21-020048
1,200 shares@ US$59.870.0023% mcap12.4% of flowCommon StockSEC:0001127602-21-020048:0
2,715 shares@ US$55.090.0047% mcap25.6% of flowCommon StockSEC:0001127602-21-019521:0
2,715 shares@ US$55.0954.3% of flowCommon StockSEC:0001127602-21-019521
26,515 sharesCommon StockSEC:0001127602-21-017675
26,515 sharesCommon StockSEC:0001127602-21-017675:0
956 shares@ US$55.9719.5% of flowCommon StockSEC:0001127602-21-017256
956 shares@ US$55.970.0017% mcap9.2% of flowCommon StockSEC:0001127602-21-017256:0
24 of 24 declarations
About Simon, Christopher
Christopher Simon is President & CEO of Haemonetics Corp. He leads the company with a focus on innovation and improving healthcare. His role involves overseeing operations and implementing strategy to ensure the growth and competitiveness of the organization.
